CellCentric raised $120m in Series C funding led by RA Capital Management, joined by Forbion, Avego Bioscience Capital, and BrightEdge.

Biotech Health services Manufacturing

United Kingdom

Netherlands

United States

Investments

09 May 2025

Share:

CellCentric (company)

United Kingdom

Biotech Health services Manufacturing

Total investments received (USD): 154.98m

Round value (USD): 120m

Round investors: Forbion Capital Partners RA Capital Management Avego Bioscience Capital BrightEdge Fund

Company: CellCentric

Industry: Biotech Health services Manufacturing

Related deals

Artios Pharma raised $115m in Series D funding co-led by SV Health Investors and RA Capital Management joined by Janus Henderson Investors and insiders.

Health services Manufacturing Pharma

United Kingdom

France

Sweden

United States

Netherlands

Switzerland

Investments 07 November 2025

Vicebio was acquired by Sanofi for $1.6B

Biotech Health services

United Kingdom

France

Secondary 14 July 2025

OrganOx was acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo in a deal valued at approximately £1.5 billion

Health services Manufacturing

United Kingdom

Japan

Secondary 14 July 2025

Draig Therapeutics raised £107m with Access Biotechnology (led), SV Health Investors, ICG, Canaan Partners, SR One, Sanofi Ventures, and Schroders Capital.

Biotech Health services Manufacturing

United Kingdom

France

Israel

United States

Investments 07 June 2025

OrganOx completed a $142 million primary and secondary equity financing led by HealthQuest Capital, joined by BGF and Lauxera Capital Partners

Health services Manufacturing

United Kingdom

France

Belgium

United States

Investments 14 February 2025